Clovis Oncology Inc (CLVS)

NASDAQ
5.62
-0.09(-1.58%)
Pre Market
5.70
+0.08(+1.42%)
- Real-time Data
  • Volume:
    3,231,163
  • Bid/Ask:
    5.69/5.77
  • Day's Range:
    5.44 - 5.89

CLVS Overview

Prev. Close
5.62
Day's Range
5.44 - 5.89
Revenue
164.52M
Open
5.8
52 wk Range
4.08 - 11.09
EPS
-4.45
Volume
3,231,163
Market Cap
587.66M
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
11,535,080
P/E Ratio
-
Beta
1.66
1-Year Change
-38.85%
Shares Outstanding
104,564,978
Next Earnings Date
Aug 04, 2021
What is your sentiment on Clovis Oncology Inc?
or
Market is currently closed. Voting is open during market hours.

Clovis Oncology Inc News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuySellSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyStrong BuyStrong SellStrong SellStrong Sell

Clovis Oncology Inc Company Profile

Clovis Oncology Inc Company Profile

Employees
429

Clovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and other international markets. The Company’s product Rubraca (rucaparib), an oral small molecule inhibitor of poly adenosine diphosphate (ADP)-ribose polymerase (PARP), is marketed in the United States for two indications specific to recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer. The Company also provides Lucitanib, which is an investigational, oral, potent inhibitor of the tyrosine kinase activity of vascular endothelial growth factor receptors one through three (VEGFR1-3), platelet-derived growth factor receptors alpha and beta, and fibroblast growth factor receptors one through three (FGFR1-3).

Read More
  • $7.4
    0
    • Price target?
      0
      • Buy time undervalue
        0
        • CLVS Earnings Revenue / Forecast 38.05M / 44.05M
          0
          • Any ideas w8ing?
            0
            • Hey readung your posts, im thinking investing isnt workjng out for you. 🤷‍♂️
              0
          • Buy time??? $quezzz
            0
            • Sell time and squeeezzzzz
              0
              • 5 60/5.40 entry tomorrow?
                0
                • Next week bottom
                  0
                  • added at dip
                    1
                    • Soon will be looking at $40-$50 range. HODL
                      0
                      • 6.20 entry?
                        0
                        • break 6.85 next should be $7.5
                          1
                          • Hold the line
                            0
                            • Is it good buy now
                              1
                              • If it is break 6.85 it will 🚀
                                1
                                • Should bounce this week
                                  0
                                  • Hold
                                    0
                                    • Short squeeze coming up hang on
                                      0
                                      • You think it will go up?
                                        0
                                        • Bouncing ball
                                          0
                                          • Low vol
                                            0
                                            • Let's open this over 10 tomorrow premarket! I'm throwing my account at this. Are YOU?!?!?!
                                              0
                                              • Let’s run to the moon
                                                1
                                            • I need a help
                                              1
                                              • Lol i sold this stock a couple weeks ago. Amazing.
                                                0
                                                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.